Randomised trial of two nicotine patch protocols distributed through a state quitline

Tobacco Control

Volumn 25, Issue 2, 2016, Pages 218-223

  Burns, Emily K ^a   Hood, Nancy E ^b   Goforth, Emma ^c   Levinson, Arnold H ^d,e  

^a Mercy Regional Medical Center   (United States)

^b Community Properties of Ohio Management Services ^*  (United States)

^c Prevention Services Division ^*  (United States)

^d Department of Civil and Environmental Engineering at Colorado State University and the Department of Environmental and Occupational Health at the Colorado School of Public Health   (United States)

^e UNIVERSITY OF COLORADO CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE; NICOTINE GUM; NICOTINIC AGENT;

ADOLESCENT; ADULT; ADVERSE EFFECTS; COMPARATIVE STUDY; CONTROLLED STUDY; COST BENEFIT ANALYSIS; CUTANEOUS DRUG ADMINISTRATION; DRUG COST; ECONOMICS; FEMALE; GOVERNMENT; GOVERNMENT REGULATION; HUMAN; MALE; MIDDLE AGED; PREVENTION AND CONTROL; PREVENTIVE HEALTH SERVICE; PROCEDURES; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; SMOKING; SMOKING CESSATION; TIME FACTOR; TOBACCO USE DISORDER; TRANSDERMAL PATCH; TREATMENT OUTCOME; YOUNG ADULT;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; COST-BENEFIT ANALYSIS; DRUG COSTS; FEMALE; GOVERNMENT REGULATION; HUMANS; LOCAL GOVERNMENT; MALE; MIDDLE AGED; NICOTINE; NICOTINIC AGONISTS; PREVENTIVE HEALTH SERVICES; SMOKING; SMOKING CESSATION; TIME FACTORS; TOBACCO USE CESSATION PRODUCTS; TOBACCO USE DISORDER; TRANSDERMAL PATCH; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84959114149     PISSN: 09644563     EISSN: 14683318     Source Type: Journal    
DOI: 10.1136/tobaccocontrol-2014-051843     Document Type: Article

References (22)

1. Fiore MC, Jaen CR, Baker TB, et al. Treating tobacco use and dependence: 2008 update. Washington, DC: US Department of Health and Human Services, 2008.
2. North American Quitline Consortium (NAQC). Free and discounted cessation medication, quitline map North America. 2012. http://map.naquitline.org/reports/ medication/
3. Stead LF, Perera R, Bullen C, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2012;11:CD000146.
4. Yudkin PL, Jones L, Lancaster T, et al. Which smokers are helped to give up smoking using transdermal nicotine patches? Results from a randomized, double-blind, placebo-controlled trial. Br J Gen Pract 1996;46:145-8.
5. Ferguson SG, Gitchell JG, Shiffman S, et al. Prediction of abstinence at 10 weeks based on smoking status at 2 weeks during a quit attempt: secondary analysis of two parallel, 10-week, randomized, double-blind, placebo-controlled clinical trials of 21-mg nicotine patch in adult smokers. Clin Ther 2009;31:1957-65.
6. An LC, Schillo BA, Kavanaugh AM, et al. Increased reach and effectiveness of a statewide tobacco quitline after the addition of access to free nicotine replacement therapy. Tob Control 2006;15:286-93.
7. Swartz SH, Cowan TM, Klayman JE, et al. Use and effectiveness of tobacco telephone counseling and nicotine therapy in Maine. Am J Prev Med 2005;29:288-94.
8. Tinkelman D, Wilson S, Willett J, et al. Offering free NRT through a tobacco quitline: impact on utilisation and quit rates. Tob Control 2007;16:42-6.
9. Cummings K, Fix B, Celestino P, et al. Reach, efficacy, and cost-effectiveness of free nicotine medication giveaway programs. J Public Health Manag Pract 2006;12:37-43.
10. Cummings KM, Hyland A, Fix B, et al. Free nicotine patch giveaway program 12-month follow-up of participants. Am J Prev Med 2006;31:181-4.
11. Hollis JF, McAfee TA, Fellows JL, et al. The effectiveness and cost effectiveness of telephone counselling and the nicotine patch in a state tobacco quitline. Tob Control 2007;16(Suppl 1):i53-9.
12. Cummings KM, Fix BV, Celestino P, et al. Does the number of free nicotine patches given to smokers calling a quitline influence quit rates: results from a quasi-experimental study. BMC Public Health 2010;10:181
13. Macleod ZR, Charles MA, Arnaldi VC, et al. Telephone counselling as an adjunct to nicotine patches in smoking cessation: a randomised controlled trial. Med J Aust 2003;179:349-52.
14. McAfee TA, Bush T, Deprey TM, et al. Nicotine patches and uninsured quitline callers. A randomized trial of two versus eight weeks. Am J Prev Med 2008;35:103-10.
15. Burns EK, Tong S, Levinson AH. Reduced NRT supplies through a quitline: smoking cessation differences. Nicotine Tob Res 2010;12:845-9.
16. Cummings KM, Hyland A, Carlin-Menter S, et al. Costs of giving out free nicotine patches through a telephone quit line. J Public Health Manag Pract 2011;17:E16-23.
17. Smith SS, Keller PA, Kobinsky KH, et al. Enhancing tobacco quitline effectiveness: identifying a superior pharmacotherapy adjuvant. Nicotine Tob Res 2013;15:718-28.
18. Saul JE, Lien R, Schillo B, et al. Outcomes and cost-effectiveness of two nicotine replacement treatment delivery models for a tobacco quitline. Int J Environ Res Public Health 2011;8:1547-59.
19. Burns EK, Levinson AH, Deaton EA. Factors in nonadherence to quitline services: smoker characteristics explain little. Health Educ Behav 2012;39:596-602.
20. North American Quitline Consortium (NAQC). Measuring quit rates. Phoenix, AZ: NAQC, 2009.
21. Hughes JR, Keely JP, Niaura RS, et al. Measures of abstinence in clinical trials: issues and recommendations. Nicotine Tob Res 2003;5:13-25.
22. Saul J, David R; the NAQC Annual Survey Workgroup. Results from the 2012 NAQC Annual Survey of Quitlines [online]. North American Quitline Consortium. http://c. ymcdn.com/sites/www.naquitline.org/resource/resmgr/2012_annual_survey/ oct23naqc_2012_final_report_.pdf (accessed 13 Oct 2014).